UPDATED Aug 19, 2025
Discover Global Pharmaceuticals & Biotech Growth Stocks from around the world. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
600200 | CN¥0.91 | -12.5% | -88.8% | CN¥653.8m | CN¥12.70 | PB0.4x | E97.5% | 0% | ||
ABS | NOK 4.15 | 22.1% | -71.4% | NOK 111.5m | n/a | PS2.5x | E97.1% | n/a | ||
HBIO | US$0.49 | 0.9% | -82.9% | US$22.5m | US$3.00 | PB1.4x | E96.7% | n/a | ||
EGTX | SEK 5.37 | -1.3% | 4.3% | SEK 1.9b | SEK 11.75 | PS41.3x | E94.8% | n/a | ||
2616 | HK$8.08 | 8.9% | 521.5% | HK$12.8b | HK$9.39 | PS53.8x | E94.5% | n/a | ||
SLV | zł33.10 | 0% | -45.6% | zł607.6m | zł49.55 | PS1.7x | E94.5% | n/a | ||
MVP | AU$0.64 | -13.0% | 38.0% | AU$78.3m | AU$2.32 | PS1.9x | E94.4% | 0% | ||
ACTI | SEK 0.18 | 8.7% | -62.1% | SEK 227.6m | n/a | PB10.5x | E94.4% | n/a | ||
MEDCL | €17.80 | 12.2% | 1.3% | €588.8m | €22.77 | PS21.2x | E94.0% | n/a | ||
LPGO | SEK 0.17 | -0.3% | -47.0% | SEK 26.0m | n/a | PS2.5x | E93.9% | n/a | ||
6919 | NT$177.50 | 32.0% | 180.4% | NT$271.4b | NT$118.50 | PS6140.8x | E93.8% | n/a | ||
9969 | HK$18.78 | 4.3% | 319.2% | HK$39.0b | HK$14.28 | PS24.9x | E93.6% | n/a | ||
300723 | CN¥70.05 | -0.9% | 343.6% | CN¥32.1b | CN¥40.26 | PS26.1x | E93.3% | 0% | ||
YCBD | US$0.63 | -33.6% | -85.6% | US$6.1m | US$3.00 | PB0.9x | E93.3% | n/a | ||
FYB | €24.95 | -1.6% | -49.5% | €440.7m | €44.00 | PS8.5x | E93.0% | n/a | ||
BINV | SEK 37.55 | 1.5% | -4.2% | SEK 2.5b | SEK 92.50 | PS40.6x | E91.8% | n/a | ||
2228 | HK$8.66 | 5.9% | 31.8% | HK$35.1b | HK$8.69 | PS120.2x | E90.8% | n/a | ||
ALZCUR | SEK 4.26 | 5.2% | 101.9% | SEK 376.1m | SEK 6.20 | PB23.4x | E90.1% | n/a | ||
STX | UK£0.07 | 53.3% | 90.5% | UK£73.4m | n/a | PS3.1x | E89.0% | n/a | ||
PLX | US$1.53 | -6.7% | 60.9% | US$122.8m | US$14.00 | PE19.4x | E88.4% | n/a | ||
PPGN | CHF 28.75 | 18.8% | -12.2% | CHF 948.5m | CHF 31.30 | PS2.7x | E88.0% | 0% | ||
ARX | AU$0.64 | 0% | 25.7% | AU$213.9m | n/a | PS2.9x | E86.2% | n/a | ||
TRUL | CA$9.87 | -4.8% | -26.5% | CA$2.1b | CA$17.89 | PS1.1x | E85.6% | n/a | ||
EXAS | US$45.68 | 9.4% | -22.3% | US$8.5b | US$62.97 | PS2.9x | E85.5% | n/a |